Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21048244rdf:typepubmed:Citationlld:pubmed
pubmed-article:21048244lifeskim:mentionsumls-concept:C0019682lld:lifeskim
pubmed-article:21048244lifeskim:mentionsumls-concept:C0019699lld:lifeskim
pubmed-article:21048244lifeskim:mentionsumls-concept:C0008059lld:lifeskim
pubmed-article:21048244lifeskim:mentionsumls-concept:C0013227lld:lifeskim
pubmed-article:21048244lifeskim:mentionsumls-concept:C0032105lld:lifeskim
pubmed-article:21048244lifeskim:mentionsumls-concept:C0674428lld:lifeskim
pubmed-article:21048244lifeskim:mentionsumls-concept:C0085155lld:lifeskim
pubmed-article:21048244lifeskim:mentionsumls-concept:C1546805lld:lifeskim
pubmed-article:21048244lifeskim:mentionsumls-concept:C0021201lld:lifeskim
pubmed-article:21048244lifeskim:mentionsumls-concept:C0332293lld:lifeskim
pubmed-article:21048244pubmed:issue10lld:pubmed
pubmed-article:21048244pubmed:dateCreated2010-11-4lld:pubmed
pubmed-article:21048244pubmed:abstractTextWe measured plasma concentration of efavirenz (EFV) in 16 HIV-infected Indian children receiving antiretroviral treatment at Government ART centres. The mean 12 hour concentration was 2.39 ug/mL (range: 0.72- 7.82 ug/mL). The majority of children treated with generic EFV at currently recommended doses had blood levels within the therapeutic range.lld:pubmed
pubmed-article:21048244pubmed:languageenglld:pubmed
pubmed-article:21048244pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21048244pubmed:citationSubsetIMlld:pubmed
pubmed-article:21048244pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21048244pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21048244pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21048244pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21048244pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21048244pubmed:statusMEDLINElld:pubmed
pubmed-article:21048244pubmed:monthOctlld:pubmed
pubmed-article:21048244pubmed:issn0974-7559lld:pubmed
pubmed-article:21048244pubmed:authorpubmed-author:VasanthaMMlld:pubmed
pubmed-article:21048244pubmed:authorpubmed-author:RamachandranG...lld:pubmed
pubmed-article:21048244pubmed:authorpubmed-author:SwaminathanSo...lld:pubmed
pubmed-article:21048244pubmed:authorpubmed-author:KumarA K...lld:pubmed
pubmed-article:21048244pubmed:authorpubmed-author:ShahIraIlld:pubmed
pubmed-article:21048244pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21048244pubmed:volume47lld:pubmed
pubmed-article:21048244pubmed:ownerNLMlld:pubmed
pubmed-article:21048244pubmed:authorsCompleteYlld:pubmed
pubmed-article:21048244pubmed:pagination890-1lld:pubmed
pubmed-article:21048244pubmed:meshHeadingpubmed-meshheading:21048244...lld:pubmed
pubmed-article:21048244pubmed:meshHeadingpubmed-meshheading:21048244...lld:pubmed
pubmed-article:21048244pubmed:meshHeadingpubmed-meshheading:21048244...lld:pubmed
pubmed-article:21048244pubmed:meshHeadingpubmed-meshheading:21048244...lld:pubmed
pubmed-article:21048244pubmed:meshHeadingpubmed-meshheading:21048244...lld:pubmed
pubmed-article:21048244pubmed:meshHeadingpubmed-meshheading:21048244...lld:pubmed
pubmed-article:21048244pubmed:meshHeadingpubmed-meshheading:21048244...lld:pubmed
pubmed-article:21048244pubmed:meshHeadingpubmed-meshheading:21048244...lld:pubmed
pubmed-article:21048244pubmed:meshHeadingpubmed-meshheading:21048244...lld:pubmed
pubmed-article:21048244pubmed:meshHeadingpubmed-meshheading:21048244...lld:pubmed
pubmed-article:21048244pubmed:year2010lld:pubmed
pubmed-article:21048244pubmed:articleTitlePlasma efavirenz in HIV infected children treated with generic antiretroviral drugs in India.lld:pubmed
pubmed-article:21048244pubmed:publicationTypeLetterlld:pubmed
pubmed-article:21048244pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed